Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1 20Phase NA 12Phase 1/2 8Phase EARLY_PHASE1 5Phase 3 3Phase 2/3 2Phase 4 1

Status

Completed 45Unknown 12Recruiting 12Terminated 9Not yet recruiting 5Active not recruiting 5Withdrawn 3Suspended 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Breast Neoplasms 25Neoplasms 19Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Carcinoma, Hepatocellular 10Urinary Bladder Neoplasms 8Ovarian Neoplasms 8Head and Neck Neoplasms 8Pain 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Lymphoma, Follicular 6Leukemia 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Non-Muscle Invasive Bladder Neoplasms 5Brain Neoplasms 5Small Cell Lung Carcinoma 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Leiomyoma 4Carcinoma 4Urologic Neoplasms 3Urogenital Neoplasms 3Papillomavirus Infections 3

Interventions

Tf-CRM107 1Temozolomide 1Procarbazine 1Isotretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × Glioblastoma × Clear all
NCT01830101 2016-03-16

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

AHS Cancer Control Alberta

Phase 3 Withdrawn
CNS

Glioblastoma

NCT00003564 2012-02-22

Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas

M.D. Anderson Cancer Center

Phase 3 Withdrawn
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00083447 2009-01-07

Study of Therapy With TransMIDâ„¢ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme

Xenova Biomedix

Phase 3 Withdrawn
323 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡